Protea announces license agreement with Yale
April 25, 2016 08:00 ET | Protea Biosciences, Inc.
MORGANTOWN, W.Va., April 25, 2016 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today that it had entered into an exclusive license agreement with Yale...
New Preclinical Data Presented at SITC Annual Meeting Highlight Bavituximab’s Enhanced Anti-Tumor Activity When Combined With Checkpoint Inhibitors in Breast Cancer and Melanoma
November 09, 2015 08:05 ET | Peregrine Pharmaceuticals Inc.
- Bavituximab in Combination with Anti-PD-1 in Breast Cancer Studies Showed a Statistically Significant Improvement in Overall Survival as Compared to Subjects Receiving Anti-PD-1 Therapy Alone - -...
radiomedix logo
Viewpoint MT and RadioMedix secured a second SBIR NCI grant for image guided therapy of metastatic melanoma
August 27, 2015 00:00 ET | RadioMedix Inc.
Houston, TX, Aug. 27, 2015 (GLOBE NEWSWIRE) -- Viewpoint Molecular Targeting LLC.(Iowa City, IO) and RadioMedix Inc. (Houston TX) partnership resulted in the second Small Business Innovation...
New Discovery Of Modified Herpes Virus May Help Cure Skin Cancer
July 25, 2015 16:34 ET | Z Skin Cosmetics
Los Angeles, CA, July 25, 2015 (GLOBE NEWSWIRE) -- While NASA may have found "Earth 2.0" named Kepler 452b, and "New Horizons" just accomplished its Pluto-fly-by, scientists on Earth have officially...
Prevent Cancer Foundation logo
The Friday before Memorial Day is Declared "Don't Fry Day" to Encourage Sun Safety and Awareness
May 19, 2015 12:06 ET | Prevent Cancer Foundation
WASHINGTON, May 19, 2015 (GLOBE NEWSWIRE) -- Skin cancer is a largely preventable disease, but it can be deadly. Skin cancer continues to be the most common type of cancer in the nation, with more...
Patient Advocate Foundation logo
Patient Advocate Foundation Receives Donation to Benefit Patients Through New Program
March 31, 2015 06:34 ET | Patient Advocate Foundation
HAMPTON, VA., March 31, 2015 (GLOBE NEWSWIRE) -- Patient Advocate Foundation (PAF) is pleased to announce the receipt of funding to support the addition of a new transportation-focused program within...
AIMLogo.jpg
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors
December 16, 2014 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today further progress on developing Ampligen® (rintatolimod)...
New Public Service Campaign Uses Humor to Urge Men Over 50 to Check Their Skin for Skin Cancer
May 27, 2014 11:30 ET | American Academy of Dermatology
SCHAUMBURG, IL--(Marketwired - May 27, 2014) -  The American Academy of Dermatology (Academy) today launched "Lawn," a public service advertisement (PSA) that encourages older men to check...
Don't Get Burned: Protect Your Skin During Outdoor Activities
May 13, 2014 12:34 ET | American Academy of Dermatology
SCHAUMBURG, IL--(Marketwired - May 13, 2014) - While warmer weather means more outdoor activities, it also means carefully protecting your skin from the sun. A common problem during spring and...
MELA Sciences Predictive Probability Study Supports Increased Diagnostic Accuracy by Dermatologists for Melanoma
May 08, 2014 08:37 ET | MELA Sciences, Inc.
IRVINGTON, NY--(Marketwired - May 8, 2014) - MELA Sciences, Inc. (NASDAQ: MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...